Übersicht			Auf mobile öffnen

Lieferstatus:	Auf Bestellung (Lieferzeit unbekannt)
Veröffentlichung:	Juni 2025
Genre:	Naturwissensch., Medizin, Technik
	Biomarkers / Biomedical engineering / Biosensors / biotechnology / Cardiovascular Disease / Clinical translation / Electronic devices and materials / Materials science / Nanobiosensors / Nanobiotechnology / Optical biosensors / Point-of-care testing / Portable Detection / Ready-to-Use / SCIENCE / Biotechnology / TECHNOLOGY & ENGINEERING / Biomedical / TECHNOLOGY & ENGINEERING / Materials Science / General / TECHNOLOGY & ENGINEERING / Sensors / Technology# general issues mehr...
ISBN:	9780443330308
EAN-Code:	9780443330308
Verlag:	Elsevier
Einband:	Kartoniert
Sprache:	English
Dimensionen:	H 235 mm / B 191 mm / D
Gewicht:	1040 gr
Bewertung:	Titel bewerten / Meinung schreiben

Inhalt:

Point-of-Care Technology for Portable Testing Devices: Nanomaterials-Based Optical Biosensors for Cardiovascular Disease Biomarkers presents the latest advances in nanomaterials-based optical biosensor-enabled point-of-care testing (PoCT) devices for the rapid and accurate detection of cardiovascular disease (CVD) biomarkers. This book begins with the introduction of novel cardiovascular biomarkers and advances in point-of-care diagnostics. Subsequent chapters focus on the selection of bioreceptors and the overview of optical nanomaterials for nanobiosensors applications. A major focus is targeted on colorimetric detection, fluorescence, chemiluminescence, Localized Surface Plasmon Resonance, and Surface-Enhanced Raman Scattering-based optical nanobiosensor signaling readout techniques, which enable the detection of CVD biomarkers. Furthermore, this book explores emerging healthcare technologies for next-generation portable PoCT devices and recent advances in nanobiosensor techniques for the rapid detection of CVD biomarkers. One dedicated chapter explores the role of artificial intelligence in enhancing point-of-care diagnostics for CVDs, while another addresses critical regulatory challenges and safety considerations in translating nanomaterial-based biosensors into clinical practice.